Viridian Therapeutics VRDN
$29.96 −$1.48 (-4.71%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $29.96 0.00%
Open$31.12
Prev close$31.44
Day range$29.87 – $31.75
Volume1.75M
Market cap$3.40B
P/E (TTM)–
Dividend yield–
Earnings
Average move on report day±10.5%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+49.4%
Worst reaction-17.2%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 4 Nov 2026 | Pre Market | ±17.6% | +15.53% | Within range |
| 2024/Q1 | 8 May 2024 | Pre Market | ±13.1% | -1.59% | Within range |
| 2023/Q1 | 9 May 2023 | After Market | ±22.8% | -1.21% | Within range |
| 2022/Q4 | 8 Mar 2023 | Pre Market | ±15.9% | -10.48% | Within range |
| 2022/Q3 | 14 Nov 2022 | Pre Market | ±19.9% | -0.93% | Within range |
| 2022/Q2 | 15 Aug 2022 | Pre Market | – | +49.36% | – |
| 2022/Q1 | 12 May 2022 | None | ±11.4% | +28.03% | Bigger than priced |
| 2021/Q4 | 10 Mar 2022 | None | ±23.6% | +5.46% | Within range |
| 2020/Q4 | 25 Mar 2021 | After Market | – | +4.75% | – |
| 2020/Q2 | 5 Aug 2020 | None | – | -6.84% | – |
| 2020/Q1 | 7 May 2020 | None | – | +7.27% | – |
| 2019/Q4 | 11 Mar 2020 | After Market | – | -16.65% | – |
| 2019/Q3 | 7 Nov 2019 | After Market | – | +0.55% | – |
| 2019/Q2 | 7 Aug 2019 | After Market | – | -17.20% | – |
| 2019/Q1 | 8 May 2019 | After Market | – | +0.00% | – |
| 2018/Q4 | 13 Mar 2019 | After Market | – | +2.64% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$25.75M-63.5% YoY
Operating profit-$103.48M-158.6% YoY
Net profit-$101.21M-192.5% YoY
Diluted EPS-$0.81-138.2% YoY
Free cash flow-$103.14M-21.7% YoY
Operating cash flow-$92.77M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin94.1%
Operating margin-1,781.4%
Net margin-1,741.9%
Return on equity-115.0%
Return on assets-57.1%
Return on invested capital-88.1%
Current ratio14.46
Liabilities / assets43.5%
Cash & investments$955.21M
Total debt$242.46M
Net cash (debt)$712.75M
No comments yet — be the first to weigh in on VRDN.
Sign in to join the discussion.